Quick Answer
CollPlant Biotechnologies Ltd reported Operating Income Loss of -$11.48 million for the year ending 2025.
- CollPlant Biotechnologies Ltd showed an increase of +33.4% in Operating Income Loss from 2024 to 2025.
- This data is from CollPlant Biotechnologies Ltd's annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), CollPlant Biotechnologies Ltd's Operating Income Loss has declined by 170.5%.
- Historical annual values: Fiscal year 2025: -$11.48 million | Fiscal year 2024: -$17.25 million | Fiscal year 2023: -$7.51 million | Fiscal year 2022: -$17.10 million | Fiscal year 2021: $65.0 thousand | Fiscal year 2020: -$5.60 million | Fiscal year 2019: -$7.63 million | Fiscal year 2018: -$4.25 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: